These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
236 related articles for article (PubMed ID: 27513190)
1. miRNA-24-3p promotes cell proliferation and regulates chemosensitivity in head and neck squamous cell carcinoma by targeting CHD5. Sun X; Xiao D; Xu T; Yuan Y Future Oncol; 2016 Dec; 12(23):2701-2712. PubMed ID: 27513190 [TBL] [Abstract][Full Text] [Related]
2. LncRNA UCA1 promotes proliferation and cisplatin resistance of oral squamous cell carcinoma by sunppressing miR-184 expression. Fang Z; Zhao J; Xie W; Sun Q; Wang H; Qiao B Cancer Med; 2017 Dec; 6(12):2897-2908. PubMed ID: 29125238 [TBL] [Abstract][Full Text] [Related]
3. Antitumor miR-150-5p and miR-150-3p inhibit cancer cell aggressiveness by targeting SPOCK1 in head and neck squamous cell carcinoma. Koshizuka K; Hanazawa T; Kikkawa N; Katada K; Okato A; Arai T; Idichi T; Osako Y; Okamoto Y; Seki N Auris Nasus Larynx; 2018 Aug; 45(4):854-865. PubMed ID: 29233721 [TBL] [Abstract][Full Text] [Related]
4. Role of Host miRNA Hsa-miR-139-3p in HPV-16-Induced Carcinomas. Sannigrahi MK; Sharma R; Singh V; Panda NK; Rattan V; Khullar M Clin Cancer Res; 2017 Jul; 23(14):3884-3895. PubMed ID: 28143871 [No Abstract] [Full Text] [Related]
5. Deep sequencing-based microRNA expression signatures in head and neck squamous cell carcinoma: dual strands of pre-miR-150 as antitumor miRNAs. Koshizuka K; Nohata N; Hanazawa T; Kikkawa N; Arai T; Okato A; Fukumoto I; Katada K; Okamoto Y; Seki N Oncotarget; 2017 May; 8(18):30288-30304. PubMed ID: 28415821 [TBL] [Abstract][Full Text] [Related]
6. Deregulation of the miR-222-ABCG2 regulatory module in tongue squamous cell carcinoma contributes to chemoresistance and enhanced migratory/invasive potential. Zhao L; Ren Y; Tang H; Wang W; He Q; Sun J; Zhou X; Wang A Oncotarget; 2015 Dec; 6(42):44538-50. PubMed ID: 26517090 [TBL] [Abstract][Full Text] [Related]
7. MicroRNA 744-3p promotes MMP-9-mediated metastasis by simultaneously suppressing PDCD4 and PTEN in laryngeal squamous cell carcinoma. Li JZ; Gao W; Lei WB; Zhao J; Chan JY; Wei WI; Ho WK; Wong TS Oncotarget; 2016 Sep; 7(36):58218-58233. PubMed ID: 27533461 [TBL] [Abstract][Full Text] [Related]
8. Elevated RET expression enhances EGFR activation and mediates EGFR inhibitor resistance in head and neck squamous cell carcinoma. Lin C; Lu W; Ren Z; Tang Y; Zhang C; Yang R; Chen Y; Cao W; Wang L; Wang X; Ji T Cancer Lett; 2016 Jul; 377(1):1-10. PubMed ID: 27090738 [TBL] [Abstract][Full Text] [Related]
9. miR-204 inhibits angiogenesis and promotes sensitivity to cetuximab in head and neck squamous cell carcinoma cells by blocking JAK2-STAT3 signaling. Wu Q; Zhao Y; Wang P Biomed Pharmacother; 2018 Mar; 99():278-285. PubMed ID: 29353201 [TBL] [Abstract][Full Text] [Related]
10. Novel C-Terminal Heat Shock Protein 90 Inhibitors (KU711 and Ku757) Are Effective in Targeting Head and Neck Squamous Cell Carcinoma Cancer Stem cells. Subramanian C; Kovatch KJ; Sim MW; Wang G; Prince ME; Carey TE; Davis R; Blagg BSJ; Cohen MS Neoplasia; 2017 Dec; 19(12):1003-1011. PubMed ID: 29121598 [TBL] [Abstract][Full Text] [Related]
11. MiR-1307 promotes ovarian cancer cell chemoresistance by targeting the ING5 expression. Chen WT; Yang YJ; Zhang ZD; An Q; Li N; Liu W; Yang B J Ovarian Res; 2017 Jan; 10(1):1. PubMed ID: 28086946 [TBL] [Abstract][Full Text] [Related]
12. Acquisition cancer stemness, mesenchymal transdifferentiation, and chemoresistance properties by chronic exposure of oral epithelial cells to arecoline. Wang TY; Peng CY; Lee SS; Chou MY; Yu CC; Chang YC Oncotarget; 2016 Dec; 7(51):84072-84081. PubMed ID: 27557511 [TBL] [Abstract][Full Text] [Related]
13. Involvement of microRNA-141-3p in 5-fluorouracil and oxaliplatin chemo-resistance in esophageal cancer cells via regulation of PTEN. Jin YY; Chen QJ; Xu K; Ren HT; Bao X; Ma YN; Wei Y; Ma HB Mol Cell Biochem; 2016 Nov; 422(1-2):161-170. PubMed ID: 27644195 [TBL] [Abstract][Full Text] [Related]
14. Livin enhances chemoresistance in head and neck squamous cell carcinoma. Yoon TM; Kim SA; Lee DH; Lee JK; Park YL; Lee KH; Chung IJ; Joo YE; Lim SC Oncol Rep; 2017 Jun; 37(6):3667-3673. PubMed ID: 28440463 [TBL] [Abstract][Full Text] [Related]
15. miR-186 regulates chemo-sensitivity to paclitaxel via targeting MAPT in non-small cell lung cancer (NSCLC). Ye J; Zhang Z; Sun L; Fang Y; Xu X; Zhou G Mol Biosyst; 2016 Oct; 12(11):3417-3424. PubMed ID: 27714074 [TBL] [Abstract][Full Text] [Related]
17. Regulation of ITGA3 by the anti-tumor miR-199 family inhibits cancer cell migration and invasion in head and neck cancer. Koshizuka K; Hanazawa T; Kikkawa N; Arai T; Okato A; Kurozumi A; Kato M; Katada K; Okamoto Y; Seki N Cancer Sci; 2017 Aug; 108(8):1681-1692. PubMed ID: 28612520 [TBL] [Abstract][Full Text] [Related]
18. miR-144-3p, a tumor suppressive microRNA targeting ETS-1 in laryngeal squamous cell carcinoma. Zhang SY; Lu ZM; Lin YF; Chen LS; Luo XN; Song XH; Chen SH; Wu YL Oncotarget; 2016 Mar; 7(10):11637-50. PubMed ID: 26826553 [TBL] [Abstract][Full Text] [Related]
19. Antagonizing miR-455-3p inhibits chemoresistance and aggressiveness in esophageal squamous cell carcinoma. Liu A; Zhu J; Wu G; Cao L; Tan Z; Zhang S; Jiang L; Wu J; Li M; Song L; Li J Mol Cancer; 2017 Jun; 16(1):106. PubMed ID: 28633632 [TBL] [Abstract][Full Text] [Related]
20. PRRX1 Regulates Cellular Phenotype Plasticity and Dormancy of Head and Neck Squamous Cell Carcinoma Through miR-642b-3p. Jiang J; Zheng M; Zhang M; Yang X; Li L; Wang SS; Wu JS; Yu XH; Wu JB; Pang X; Tang YJ; Tang YL; Liang XH Neoplasia; 2019 Feb; 21(2):216-229. PubMed ID: 30622052 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]